Profound Medical (PROF) Current Deferred Revenue (2023 - 2025)
Historic Current Deferred Revenue for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $434000.0.
- Profound Medical's Current Deferred Revenue fell 4581.77% to $434000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $434000.0, marking a year-over-year decrease of 4581.77%. This contributed to the annual value of $419000.0 for FY2024, which is 4244.51% down from last year.
- Latest data reveals that Profound Medical reported Current Deferred Revenue of $434000.0 as of Q3 2025, which was down 4581.77% from $694000.0 recorded in Q2 2025.
- Profound Medical's 5-year Current Deferred Revenue high stood at $752.0 million for Q1 2023, and its period low was $142000.0 during Q2 2023.
- Its 3-year average for Current Deferred Revenue is $68.8 million, with a median of $636000.0 in 2025.
- The largest annual percentage gain for Profound Medical's Current Deferred Revenue in the last 5 years was 41760.56% (2024), contrasted with its biggest fall of 9997.18% (2024).
- Profound Medical's Current Deferred Revenue (Quarter) stood at $728000.0 in 2023, then crashed by 42.45% to $419000.0 in 2024, then increased by 3.58% to $434000.0 in 2025.
- Its Current Deferred Revenue stands at $434000.0 for Q3 2025, versus $694000.0 for Q2 2025 and $636000.0 for Q1 2025.